Your search for DAA returned 33 results.

Perfectovir is a realizable goal: an HCV revolution

The development of “Perfectovir” is a realizable goal: a revolution in the treatment of Hepatitis C has begun! The key attributes of an optimal HCV treatment regimen were recently outlined by Gregory Dore and Jordan Feld in an invited review article published in the journal Clinical Infectious Diseases (Dore GJ, Feld JJ. Clin Infect Dis. 2015 Mar 11. pii: ...

Read More

Two DAA regimen effective in difficult to treat HCV

Regimen of two direct-acting oral antivirals appears effective in patients with difficult to treat HCV subgenotypes 1a and 2b Therapies for HCV genotype 1, 2, and 3 infection have traditionally been peginterferon (pegIFN)-based. PegIFN is associated with adverse events including influenza-like symptoms and depression. Many patients decline PegIFN therapy, and a ...

Read More

A Truly Historic Era in Hepatitis C Therapy

We are entering a truly historic era in hepatitis C therapy. The recent introduction of oral, well-tolerated, limited-duration therapies with over 95% cure rates makes the once unrealistic aspiration of eradicating hepatitis C infection a realizable goal. However, several major hurdles need to be cleared before this objective can be achieved. Foremost is the identi...

Read More